chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient experienced vomiting, fever, chills, and shaking the evening of vaccinations (9/28/20). The next morning (9/29/20) her skin was hurting, legs were sore, and her chest was hurting. Patient stated she never experienced injection site reactions on either arm. After alternating acetaminophen and ibuprofen for 2 days, her symptoms have completely resolved as of 9/30/20.
6 days after the shot I got "Covid Arm" and reported it to you. Now 13 days out, I got REALLY sick! Chills, fever (102.4) nausea, sore throat, slight cough, loss of appetite and it has lasted until tonight 4/20/21/.. I am finally feeling a bit better BUT still not right. The idea of having a 2nd injection is off the table. They say you get sick with the 2nd. I surely don't want to get any sicker than I am.
Extreme soreness in right arm/shoulder area immediately after first shot,lasted for about four days; Extreme soreness in right arm/shoulder area immediately after first shot, lasted for about four days; This is a spontaneous report from a non-contactable consumer (patient). A 46-years-old no -pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number EW0167), via an unspecified route of administration, administered in Arm Right on 22May2021 13:30 as DOSE 1, SINGLE for covid-19 immunisation. No known allergies. The patient did not take no other vaccine in four weeks. The patient medical history was not reported. Concomitant medications included colecalciferol (VITAMIN D) taken for an unspecified indication, start and stop date were not reported; zinc taken for an unspecified indication, start and stop date were not reported; probiotics taken for an unspecified indication, start and stop date were not reported. On an unspecified date the patient experienced extreme soreness in right arm/shoulder area immediately after first shot, lasted for about four days. No COVID prior vaccination, and no COVID tested post vaccination. The patient did not receive any treatment. The outcome of the event was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Within 3 minutes, had facial tingling and numbness. Tongue felt ?thick? with it 30 minutes. Received 50 ml injection at that time. All symptoms resolved within 5 hours.
Injection was particularly painful and area was sore immediately following.  Soreness at the muscle grew steadily worse and now having difficulty raising the left arm overhead as it is too painful.  Shoulder/deltoid area is sore even when not in use.
Approximately 2-3 hours after vaccine experience, chest pains (previous MI), fever/chills, sweats, body aches
Patient had redness and swelling in left arm that extended all the way around and went from elbow to shoulder. Patient took TYLENOL and BENADRYL which helped the itching. Patient also reported feeling nausea but wasn't sure if it was from the immunization. Patient to follow up with Dr and monitor for worsening of symptoms.
Vaccine expired on 13-OCT-2021 and placed in refrigerator on 18-OCT-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine expired on 13-OCT-2021 and placed in refrigerator on 18-OCT-2021) and EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13-OCT-2021 and placed in refrigerator on 18-OCT-2021). At the time of the report, PRODUCT STORAGE ERROR (Vaccine expired on 13-OCT-2021 and placed in refrigerator on 18-OCT-2021) and EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. The vial did not undergo any temperature excursion and patient did not experienced any adverse events.
This spontaneous report was received from a physician, referring to a patient of unspecified age and gender. The patient's concomitant medication, pertinent medical history, drug reactions and allergies information was not provided. The physician reported that, on 26-FEB-2018, the patient was vaccinated with the M-M-R II lot number M045390 and expiration date 14-NOV-2018; subcutaneously, in the right upper arm, for prophylaxis. It was also reported that the M-M-R II was reconstituted with 0.4% sodium chloride (manufacturer unknown) lot number U5858BA and expiration date 28-JUN-2018. The physician reported that no adverse effects were experienced by the patient.
A mother reported that her 9 month old son received his 1st dose of Prevnar and subsequently experienced irritability and crying. He recovered.
The patient was vaccinated with the second dose of the Pfizer COVID-19 vaccine on 9/7/21. He developed headache , abdominal pain, and general body aches on 9/10/21. On the morning of  9/11/21 he developed sudden onset mid sternal chest pain and left arm tingling. He was evaluated at a local ER and troponin was elevated at 1.73 and EKG showed ST elevations. He was transferred and admitted to Cardiac ICU on 9/11/21 for monitoring. On admission, repeat troponin level was 5.76. EKG and echocardiogram were normal on admission. Troponin peaked at 7.57 on 9/11/21 and then gradually declined. By discharge home on 9/14/21, troponin level was down to 0.29. No medications were administered during hospitalization. Close monitoring and serial troponin levels were performed. He remained hemodynamically stable and breathing room air during his hospitalization. Chest pain resolved 24 hrs after admission.
Red, swollen area to left arm (deltoid), fever to area; site approximately 14cm in diameter.  Afebrile.
pt felt ill (weak, tired) day p/vax;6NOV98 rash bilat on both axilla;rash cont down side;itchy;allerg rxn to the vax;
Patient appeared to faint in the chair just moments/seconds after receiving the vaccine. Patient became pale, clammy, and was slightly dizzy as he became alert from the episode. Mom stated he nearly fainted from a finger-stick blood sample before, but has not fainted fully. Ice pack was applied to the patient's neck. Juice was offered, but patient declined and requested water. Once able, patient was placed in a lying position on a cot and monitored and offered support for approximately 20 minutes. Pt regained color and felt comfortable standing/walking/leaving at that point.
SEVERE SIDE EFFECTS; NASTY FEVER LASTING MORE THAN 24 HRS; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced severe side effects, and nasty fever lasting more than 24 hrs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nasty fever lasting more than 24 hrs and severe side effects was not reported. This report was non-serious. This case, from the same reporter is linked to 20210420571.
Elevated heart rate at 240 beats per minute that did not subside along with shortness of breath  and mild chest pain. 911 was called I was transported to Emergency Department. Prior to leaving leaving in ambulance I was given Adenosine to lower my heart rate.
Headache, nausea, dizziness, diarrhea, body aches, fatigue began at approximately 24 hours post injection and continued for 24 hours.  Continued to have daily severe headaches and mild body ache/fatigue for 1 week post vaccination.
Injection was very high on left deltoid, felt like almost joint instead of muscle.    By evening shoulder was very sore, got worse through the night - it felt similar to a torn ligament I had years ago.    By Friday morning, I could not lift arm, started taking Advil.   This continued Saturday.  Pain started to diminish Saturday night.  Pain and mobility improved Sunday.  By Monday morning, almost 4 days after injection, shoulder was normal.   I contacted Dr. on Monday, thinking the location of the injection had caused the problem.  He was going to talk to the person who gave the injection to make sure she gives future shots in the center of the deltoid.  He also encouraged me to do this report to the CDC.
Patient reported swelling above the elbow on the right arm (below the injection site). Symptoms appeared within 24 hours of vaccination.
pt recvd vax; woke up w/ swollen lt arm; called hlth dept & was advised to put ice on the arm; arm was very hot & swollen; to clinic in town;given prescription for ibuprofen & cephalosporin
This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a male patient who received BEXSERO (batch number 157501, expiry date August 2017). On 7th April 2017, the patient received BEXSERO. On an unknown date, less than a month after receiving BEXSERO, the patient experienced pain in arm, myalgia upper extremities and loss of sensation. On an unknown date, the outcome of the patient in arm, myalgia upper extremities and loss of sensation were unknown. It was unknown if the reporter considered the pain in arm, myalgia upper extremities and loss of sensation to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. On 20th April 2017, reporter received a call from the guardian (Mother of the patient) reporting pain, myalgia and loss of some sensation all over the arm where the vaccine was administered, still 13 days after administration of vaccine. The patient's mother was oriented about side effects and was told to visit his paediatrician who is in the same office for proper evaluation. However, the patient mother never calls back for feedback or set an appointment with patient's paediatrician. By the time the patient mother report the event, she hadn't either visited any other to inform and request evaluation.
No adverse event; Patient received a 0.25 ml dose as booster from booster dose only presentation vial; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received a 0.25 ml dose as booster from booster dose only presentation vial) and NO ADVERSE EVENT (No adverse event) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In July 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 25 microgram. In July 2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received a 0.25 ml dose as booster from booster dose only presentation vial). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received a 0.25 ml dose as booster from booster dose only presentation vial) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received a 0.25 ml dose as booster from booster dose only presentation vial).    No concomitant product use was reported.  Vaccination dates reported as between 22-Jul-2022 and 28-Jul-2022. Patient received booster dose (0.25 ml). It was unknown if patient experienced any symptoms after getting the vaccine. Treatment information was not provided.
Erythema, induration, warmth 6 x 8 inch area around injection site / ? allergy
pt recvd MMR vax 3NOV88 & 25FEB91 devel congestion & a cough; dx OM; 13MAR92 it was found that ear infect had not resolved; 22MAR91 temp, cough dx clinicial strep; pos conjunctivitis, Koplik's spot, mac pap rash, red tongue;
24 hours after vaccine, had fatigue, lymph node swelling that lasted 1 week, joint pain starting the next day in knees and ankles. Then 4th finger on right hand that has pins in it started to swell and become painful in the 8th two days later the ring finger on other hand started to swell and become painful, then pinky swelling on both hands a day after that. Then pain and swelling started to subside around the 22nd then gone by the 24th. I am supposed to get my second vaccine tomorrow and I am wondering if this is still advised or will lead to a much more severe response. I reported weeks ago and never heard back from anyone.
Was well at time of vaccination on 29 Sep. The following day he woke up with a runny nose and feeling a little weak. During the PM he developed chest discomfort, like an elephant sitting on chest, rated 8/10. No radiation, no n/v/diaphoresis. Reported SOB and pain increased when he was on his back. He went to the ED later that PM and was admitted. He denied problems with previous immunizations and never had pain like this before. He stated he was told he had pericarditis. Symptoms: CHEST PAIN, UNSPECIFIED (R079), OTH SPEC DISORD, NOSE & NAS SINES (J3489), WEAKNESS (R531).
shortness of breath; elevated heart rate; dizziness; vertigo; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), HEART RATE INCREASED (elevated heart rate), DIZZINESS (dizziness), VERTIGO (vertigo) and FATIGUE (exhaustion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), HEART RATE INCREASED (elevated heart rate), DIZZINESS (dizziness), VERTIGO (vertigo) and FATIGUE (exhaustion). At the time of the report, DYSPNOEA (shortness of breath), HEART RATE INCREASED (elevated heart rate), DIZZINESS (dizziness), VERTIGO (vertigo) and FATIGUE (exhaustion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.
Swelling of lymph node in the right armpit.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0182) via an unspecified route of administration in the right arm on 11May2021 at 11:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to birch pollen and raw carrots. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0164) via an unspecified route of administration in the right arm on 20Apr2021 at 09:00, as a single dose for COVID-19 immunisation. On 12May2021 at 00:00, the patient experienced swelling of lymph node in the right armpit. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swelling of lymph node in the right armpit was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Could not breath, burning in my breast and red in the breast skin and arms, inflammation in my joints, swollen hands
Prior to vaccination patient was crying and breathing fast.  Immediately after vaccination patient said she felt dizzy.  One hour post vaccination, patient's mother called and said patient had a severe headache.
Patient passed out after receiving the vaccines. He was sitting in the chair when he passed out, falling to the floor.
arm soreness; muscle aches all over the body; Fatigue; 5 months pregnant;received both doses of Moderna COVID-19 vaccine; This spontaneous prospective pregnancy case was reported by a paramedic and describes the occurrence of PAIN IN EXTREMITY (arm soreness), MATERNAL EXPOSURE DURING PREGNANCY (5 months pregnant;received both doses of Moderna COVID-19 vaccine), MYALGIA (muscle aches all over the body) and FATIGUE (Fatigue) in a 32-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included Delivery (Patient had Pre-Eclampsia (week 38) Pregnancy outcome: Live, Full-term birth) on 28-Nov-2018. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy.   On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 11-Sep-2020 and the estimated date of delivery was 17-Jun-2021. On 27-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (5 months pregnant;received both doses of Moderna COVID-19 vaccine). On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), MYALGIA (muscle aches all over the body) and FATIGUE (Fatigue). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifth month of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 26-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (5 months pregnant;received both doses of Moderna COVID-19 vaccine) had resolved. On 28-Jan-2021, PAIN IN EXTREMITY (arm soreness), MYALGIA (muscle aches all over the body) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2020, Pregnancy test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported of having an allergy to dairy products.  No treatment information was provided by the reporter.
TOOK TWO DOSES IN A ROW; This spontaneous case report was received from a consumer (PVX2019-304) on 01-Feb-2019. The report describes a 61-year-old adult female consumer who "took two doses in a row". The consumer was receiving oral Vivotif (one capsule every other day) for typhoid prevention.  It was reported that the consumer took the two doses of Vivotif in a row. The doses were taken on 30-Jan-2019 and 31-Jan-2019, respectively.  The action taken with Vivotif with respect to the event "took two doses in a row" was not applicable.  The clinical outcome of the event "took two doses in a row" was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
Patient came in with the intention of getting a Shingrix dose for her first shot, and ended up getting a high dose flu shot instead.  Patient had not had a flu shot prior so it wasn't a double dose, she didn't indicate which shot she wanted on the form, but was expecting a Shingrix shot.  The next day she was reviewing the paperwork and called me pretty upset because she didn't get what she had asked for.  She did not say anything about side effects or that she had already had the flu shot....she had asked the immunizing pharmacist if "it was the new shot" and the pharmacist thought she was asking if it was the high dose shot.  Patient was understandingly quite upset.
15 hours after 2nd injection I developed fever, chills, sore throat, body aches  9 days after 2nd injection I developed itchy burning  rash on left arm, 11 days after 2nd injection I noticed the rash had spread to right arm and chest, 13 days after 2nd injection I sought medical treatment as injection site remained itchy and red/rashy, both arms remained itchy and chest rash was severe and spread to neck/back and left ear.
This spontaneous report was received from a pharmacist refers to a 67 year old male patient. On 19-FEB-2013, the patient was vaccinated with ZOSTAVAX, (lot number reported as H020845, expiry date was 20-FEB-2014, route was subcutaneous). Concomitant therapy included PRAVASTATIN. On 20-FEB-2013, the patient was prescribed prednisone for inflammation because the patient's past injury on the leg had become exacerbated after receiving a dose of ZOSTAVAX. Laboratory diagnostics were not performed. Treatment rendered for the event was prednisone. The outcome of the event was reported as recovering. It was reported that the patient sought medical attention. Additional information has been requested.
8.5 cm x 6 cm redness w/some induration of area, tender and warm on day after vaccine. Developed myalgia, nausea, headache, stiffness on left entire arm and redness at site day of vaccination. Treated with cephalexin 10d.
Soreness at injection site; Tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE PAIN (Tenderness at injection site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE PAIN (Tenderness at injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at injection site) had resolved and VACCINATION SITE PAIN (Tenderness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter. Treatment of events was not reported.
Within 24 hours I had extreme pain where I have Arthritis. Day 3 I started to get light headed while sitting. Lasted all day and did not make a difference if I was sitting or standing.
MINUTES AFTER RECEIVING VACCINE PT STARTED TO FEEL DIZZING, BLURRED VISION (SEEING DOTS), FEELING CLAMY, COLD, TONGUE TINGLING, NAUSEA. PT WAS ABLE TO VERBALLY COMMUNICATE WHAT SHE WAS FEELING. RPH ON DUTY CALLED 911
Emergency Room - Refer To Physician (Headache, Light Headed, Dizziness, Confusion, Body Aches, Upset Stomach, No Drive)
Dull chest pain which increased with deep breath or bending over. Blood tests revealed extremely elevated Tropinin-i and CRP levels. Required hospital stay, for 2 days
Narrative:  Received a Covid booster on 10/13 and had a reaction that evening (fever, facial and tounge swelling and alterted mental status). Was briefly in the hospital. Patient added that he had a blood glucose over 400 and was ill. He was given prednisone for 3 days.